Article
Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease.
International journal of molecular medicine - 1 May 2006
Kölsch Heike, Lütjohann Dieter, Jessen Frank, Von Bergmann Klaus, Schmitz Sandra, Urbach Horst, Maier Wolfgang, Heun Reinhard
Abstract excerpt
The ATP-binding cassette transporter A1 (ABCA1) mediates reverse cholesterol transport, polymorphisms have been shown to influence the levels of cholesterol and of HDL and the risk of coronary artery disease. Since altered cholesterol metabolism is also involved in Alzheimer's disease (AD), the effects of two ABCA1 polymorphisms (G-395C promoter polymorphism (rs 2246293) and exonic R219K) on the risk of AD in 241...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
